½ÃÀ庸°í¼­
»óǰÄÚµå
1585790

±ÙÁ¢Ä¡·á ±â±â½ÃÀå : Á¦Ç°, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Brachytherapy Devices Market by Product (Brachytherapy Afterloader, Brachytherapy Applicators), Technique (High Dose Rate Brachytherapy Devices, Low Dose Rate Brachytherapy Devices), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±ÙÁ¢Ä¡·á ±â±â ½ÃÀåÀº 2023³â¿¡ 12¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 14¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 13.54%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2030³â¿¡´Â 30¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹æ»ç¼± Ä¡·á±â´Â ¾Ï Ä¡·á¿¡¼­ Áß¿äÇÑ µµ±¸·Î, Á¾¾ç ±Ùó ¶Ç´Â Á¾¾ç ³»¿¡ ¹æ»ç¼º ¹æ»ç¼±¿øÀ» ¹èÄ¡ÇÏ¿© ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸ鼭 Ç¥ÀûÈ­µÈ ¹æ»ç¼± Ä¡·á¸¦ ¼öÇàÇÕ´Ï´Ù. ƯÈ÷ Àü¸³¼±¾Ï, ÀڱðæºÎ¾Ï, À¯¹æ¾Ï, ÇÇºÎ¾Ï µîÀÇ Ä¡·á¿¡¼­ °í¼±·®ÀÇ ¹æ»ç¼±À» ´Ü½Ã°£¿¡ Á¶»çÇÏ¿© ÀÔ¿ø ±â°£À» ´ÜÃàÇϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä »ç¿ëó´Â º´¿ø Á¾¾çÇаú ¹× Àü¹® ¾Ï Ä¡·á ¼¾ÅÍÀ̸ç, ÃÖÁ¾ »ç¿ëÀÚ´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, ÀÓ»óÀÇ»ç, ¾Ï ȯÀÚ µîÀÔ´Ï´Ù. ¹æ»ç¼± Ä¡·á ±â±â ½ÃÀåÀº ±â¼ú ¹ßÀü, ¾Ï ¹ßº´·ü Áõ°¡, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µîÀÇ ¿äÀο¡ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼±Áø±¹¿¡¼­´Â ¾Ï Ä¡·á °³¼±À» À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ¼ºÀå ÀáÀç·ÂÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. Ä¡·á °èȹ¿¡ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ºñÁ¾¾ç¼º Áúȯ¿¡ ´ëÇÑ Àû¿ë È®´ë, ÈÞ´ë°¡ °¡´ÉÇϰí ȯÀÚ Ä£È­ÀûÀÎ ±â±â °³¹ß µîÀÌ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ä¡·á ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¼÷·ÃµÈ Àü¹®°¡ÀÇ Á¦ÇÑÀûÀÎ °¡¿ë¼º µîÀÌ Å« À庮À¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿ÜºÎ ¹æ»ç¼± ¿ä¹ýÀ̳ª ¼ö¼úÀû Ä¡·á¿Í °°Àº ´ëü ¿ä¹ý°úÀÇ °æÀïµµ ½ÃÀåÀÇ ÇѰè·Î ²ÅÈü´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí Á¤¹ÐÀÇ·á, °³ÀÎÈ­µÈ ¼±·® °è»ê, ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀÇ Çõ½ÅÀº ¼ºÀåÀÇ ±æÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. ±â±â ±â´É °­È­, ȯÀÚ ÆíÀǼº Çâ»ó, Ä¡·á ¿ëµµ È®´ë¸¦ À§ÇÑ ¿¬±¸°³¹ß¿¡ ÁßÁ¡À» µÎ¸é ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àåºñ Á¦Á¶¾÷ü¿Í Á¾¾çÇÐ Àü¹®°¡µéÀÌ ½ÇÁ¦ µ¥ÀÌÅÍ ¼öÁý ¹× ÀÀ¿ë ºÐ¾ß¿¡ ƯȭµÈ ±â¼ú Çõ½ÅÀ» À§ÇØ Çù·ÂÇÏ´Â °ÍÀÌ ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀÔ´Ï´Ù. ¹æ»ç¼± Ä¡·á ±â±â ½ÃÀåÀº Æ´»õ ½ÃÀåÀÌÁö¸¸, ÷´ÜÀûÀÌ°í ´ú ħ½ÀÀûÀÎ ¾Ï Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä°¡ Ư¡ÀÔ´Ï´Ù. ±â¾÷µéÀº ±â¼ú ¿¬±¸ ÅõÀÚ, Àû¿ë ¹üÀ§ È®´ë, ½Ã¼úÀÚ ±³À° ÇÁ·Î±×·¥ °­È­ µîÀ» ÅëÇØ ÀÌ·¯ÇÑ °æÀï ¿ìÀ§¸¦ À¯ÁöÇϰí ȯÀÚ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ ÀÌ·¯ÇÑ °æÀïÀû °í·Á»çÇ×À» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 12¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 14¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 30¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 13.54%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±ÙÁ¢Ä¡·á ±â±â½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

±ÙÁ¢Ä¡·á ±â±â½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â ¾ÏÀÇ À¯º´·ü
    • °íÁ¤¹ÐÇϰí Ç¥ÀûÈ­µÈ ¹æ»ç¼± Ä¡·á·Î ÀÎÇÑ Å« ¼ö¿ä
    • ¾Ï Ä¡·á¿¡ ´ëÇÑ Á¤ºÎÀÇ ¿ìÈ£Àû Áö¿ø
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÅÈï±¹¿¡¼­ÀÇ »óȯ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ºê¶óŰÅ×¶óÇÇÀÇ ½Å±â¼ú
    • ÃֽŠºê¶óŰÅ×¶óÇÇ¿ë ±â±â ¼Ò°³
  • ½ÃÀå °úÁ¦
    • ¹æ»ç¼± Ä¡·á¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦¿Í ¹æ»ç¼± Ä¡·á ±â±â

Portre's Five Forces : ºê¶óŰÅ×¶óÇÇ ±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ºê¶óŰÅ×¶óÇÇ ±â±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¹æ»ç¼± Ä¡·á ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ±ÙÁ¢Ä¡·á ±â±â½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

±ÙÁ¢Ä¡·á ±â±â½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ±ÙÁ¢Ä¡·á ±â±â½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¹æ»ç¼± Ä¡·á ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ±ÙÁ¢Ä¡·á ±â±â½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

±ÙÁ¢Ä¡·á ±â±â½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå : Á¦Ç°º°

  • Brachytherapy Afterloader
  • Brachytherapy Applicators

Á¦7Àå ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå : ±â¼úº°

  • °í¼±·®À² ±ÙÁ¢Ä¡·á ±â±â
  • Àú¼±·®À² ±ÙÁ¢Ä¡·á ±â±â

Á¦8Àå ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå : ¿ëµµº°

  • À¯¹æ¾Ï
  • ºÎÀΰú ¾Ï
  • Àü¸³¼±¾Ï

Á¦9Àå ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Á¾¾çÇÐ ¼¾ÅÍ

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Becton, Dickinson and Company
  • Biobot Surgical Pte Ltd.
  • Boston Scientific Corporation
  • C4 Imaging LLC
  • Carl Zeiss AG
  • CivaTech Oncology
  • Dexur Inc.
  • Eckert & Ziegler BEBIG S.A.
  • Elekta AB
  • General Electric Company
  • Guangzhou Perception Vision Medical Technologies Co.,Ltd.
  • Hologic Inc.
  • iCAD, Inc.
  • IsoAid, LLC
  • Merit Medical Systems, Inc.
  • Mick Radio-Nuclear Instruments Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Perspective Therapeutics
  • Qfix
  • SeeDOS Ltd.
  • Siemens Healthineers AG
  • Sun Nuclear Corporation
  • Theragenics Corporation
  • Valco Instruments Company Incorporated
  • Varian Medical Systems Inc.
LSH 24.11.13

The Brachytherapy Devices Market was valued at USD 1.25 billion in 2023, expected to reach USD 1.41 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 3.04 billion by 2030.

Brachytherapy devices are critical tools in cancer treatment, where radioactive sources are placed near or within the tumor to provide targeted radiation therapy, minimizing damage to surrounding healthy tissues. The necessity of these devices lies in their ability to deliver high doses of radiation in short periods, reducing hospital stays and enhancing patient outcomes, particularly in prostate, cervical, breast, and skin cancer treatment. The primary application is in oncology departments of hospitals and specialized cancer treatment centers, with end-users including healthcare providers, clinicians, and cancer patients. The market for brachytherapy devices is influenced by factors such as technological advancements, rising cancer incidences, and increasing awareness about minimally invasive procedures. Additionally, government initiatives to improve cancer care and reimbursement policies in developed economies present growth potential. Opportunities emerge from the integration of AI and machine learning in treatment planning, expanding applications in non-oncological diseases, and the development of portable and patient-friendly devices. However, challenges such as high treatment costs, stringent regulatory requirements, and limited availability of trained professionals pose significant barriers. Market limitations include competition from alternative therapies like external beam radiotherapy and surgical options. Despite these challenges, innovation in precision medicine, personalized dose calculation, and cost-effective solutions present avenues for growth. Emphasizing R&D to enhance device capabilities, improve patient comfort, and extend therapeutic applications can foster market expansion. Furthermore, collaborations between device manufacturers and oncology specialists for real-world data collection and application-specific innovations can drive market leadership. The brachytherapy device market, although niche, is characterized by a consistent demand for advanced, less invasive cancer treatment options. Companies can leverage these insights by investing in technological research, broadening application scopes, and enhancing practitioner training programs to maintain competitive advantage and improve patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 1.25 billion
Estimated Year [2024] USD 1.41 billion
Forecast Year [2030] USD 3.04 billion
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brachytherapy Devices Market

The Brachytherapy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cancer across the globe
    • Significant demand due to high precision and targeted radiotherapy
    • Favorable government support for cancer treatment
  • Market Restraints
    • Lack of reimbursement in developing countries
  • Market Opportunities
    • Emerging technologies in brachytherapy
    • Introduction of new devices for modern brachytherapy
  • Market Challenges
    • Stringent regulations for radiation therapies and brachytherapy devices

Porter's Five Forces: A Strategic Tool for Navigating the Brachytherapy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brachytherapy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brachytherapy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brachytherapy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brachytherapy Devices Market

A detailed market share analysis in the Brachytherapy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brachytherapy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brachytherapy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brachytherapy Devices Market

A strategic analysis of the Brachytherapy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Devices Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Biobot Surgical Pte Ltd., Boston Scientific Corporation, C4 Imaging LLC, Carl Zeiss AG, CivaTech Oncology, Dexur Inc., Eckert & Ziegler BEBIG S.A., Elekta AB, General Electric Company, Guangzhou Perception Vision Medical Technologies Co.,Ltd., Hologic Inc., iCAD, Inc., IsoAid, LLC, Merit Medical Systems, Inc., Mick Radio-Nuclear Instruments Inc., Panacea Medical Technologies Pvt. Ltd., Perspective Therapeutics, Qfix, SeeDOS Ltd., Siemens Healthineers AG, Sun Nuclear Corporation, Theragenics Corporation, Valco Instruments Company Incorporated, and Varian Medical Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Brachytherapy Afterloader and Brachytherapy Applicators.
  • Based on Technique, market is studied across High Dose Rate Brachytherapy Devices and Low Dose Rate Brachytherapy Devices.
  • Based on Application, market is studied across Breast Cancer, Gynecologic Cancer, and Prostate Cancer.
  • Based on End-User, market is studied across Hospitals and Onchology Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cancer across the globe
      • 5.1.1.2. Significant demand due to high precision and targeted radiotherapy
      • 5.1.1.3. Favorable government support for cancer treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement in developing countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technologies in brachytherapy
      • 5.1.3.2. Introduction of new devices for modern brachytherapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for radiation therapies and brachytherapy devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Brachytherapy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Brachytherapy Afterloader
  • 6.3. Brachytherapy Applicators

7. Brachytherapy Devices Market, by Technique

  • 7.1. Introduction
  • 7.2. High Dose Rate Brachytherapy Devices
  • 7.3. Low Dose Rate Brachytherapy Devices

8. Brachytherapy Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Gynecologic Cancer
  • 8.4. Prostate Cancer

9. Brachytherapy Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Onchology Centers

10. Americas Brachytherapy Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Brachytherapy Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Brachytherapy Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Biobot Surgical Pte Ltd.
  • 3. Boston Scientific Corporation
  • 4. C4 Imaging LLC
  • 5. Carl Zeiss AG
  • 6. CivaTech Oncology
  • 7. Dexur Inc.
  • 8. Eckert & Ziegler BEBIG S.A.
  • 9. Elekta AB
  • 10. General Electric Company
  • 11. Guangzhou Perception Vision Medical Technologies Co.,Ltd.
  • 12. Hologic Inc.
  • 13. iCAD, Inc.
  • 14. IsoAid, LLC
  • 15. Merit Medical Systems, Inc.
  • 16. Mick Radio-Nuclear Instruments Inc.
  • 17. Panacea Medical Technologies Pvt. Ltd.
  • 18. Perspective Therapeutics
  • 19. Qfix
  • 20. SeeDOS Ltd.
  • 21. Siemens Healthineers AG
  • 22. Sun Nuclear Corporation
  • 23. Theragenics Corporation
  • 24. Valco Instruments Company Incorporated
  • 25. Varian Medical Systems Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦